DGAP-News: MediClin AG: Sales up by EUR 1.8 mill. in the 1st quarter 2011
(firmenpresse) - DGAP-News: MediClin AG / Key word(s): Quarter Results
MediClin AG: Sales up by EUR 1.8 mill. in the 1st quarter 2011
11.05.2011 / 08:54
---------------------------------------------------------------------
Offenburg, 11 May 2011 -MEDICLIN Aktiengesellschaft (MediClin) achieved
Group sales of EUR 120.0 mill. (Q1 2010: EUR 118,2 mill) for the first
three months of the FY 2011, thus EUR 1.8 mill or 1.5 % more than in the
comparable previous year's quarter. Despite increased Group sales the
Group's operating result of EUR -0.5 mill. was EUR 0.5 mill. less than the
previous year's value. Decisive here were primarily higher
quarter-on-quarter staff costs (EUR +2.9 mill.).The result attributable to
the shareholders of MediClin amounted to EUR-2.0 mill. (Q1 2010: EUR -1.6
mill.).
In the acute segment increased sales could offset higher costs
Sales in the post-acute segment amounted to EUR 66.3 mill., or were EUR 0.1
mill. higher than the previous year's value. Costs including depreciation
and amortisation rose as compared to the same period last year by EUR 1.7
mill., leading to a decreased segment result of EUR -3.3 mill. Sales in the
acute segment increased by EUR 1.2 mill. to EUR 50.4 mill. Here the
revenues could offset the higher costs, so that the segment result improved
from EUR 4.1 mill. to EUR 4.6 mill. In both segments, staff costs are the
largest cost item, representing 54.3 % (post-acute) and 51.4 % (acute) of
overall costs.
Proposal of a dividend payment
As business development in 2010 was satisfactory, and the Management Board
foresee stable economic environment as well as a stable labour market in
2011, the Management Board and the Supervisory Board will propose a
dividend of EUR 0.05 per share for the 2010 financial year at the Annual
General Meeting on 26 May 2011.
Market development and outlook
In the post-acute segment, the lower indication-based reference values
decreed by the German Pension Fund since the end of 2010 for the average
length of patient stay and an altered authorisation procedure for certain
indications becoming noticeable. There are no signs, however, that there
will be lower utilisation of budgets in 2011 on the part of the coverage
providers.
In 2011, MediClin will invest in internal growth, and as far as the
framework conditions of the industry and the referral behaviour of the
coverage providers do not seriously alter in 2011, the Management Board
expects a slight increase in turnover as well as an results comparable to
the previous year. In terms of external growth, acquisition efforts will be
focused on the acute sector.
The interim report Q1 2011 is available under www.mediclin.de in German und
English.
About MediClin AG (Ticker: MED; ISIN: DE0006595101)
MediClin AG is a nation-wide clinic operator and large provider of services
in the area of Psycho- and Neurosciences as well as Orthopaedic. With 34
clinics and 7 nursing care facilities and 11 Medizinische
Versorgungszentren (medical care units) in 11 federal states MediClin has a
total capacity of approximately 8,000 beds. MediClins' facilities include
acute care clinics, i.e., general hospitals, special treatment facilities,
specialised hospitals and clinics for post-acute treatment and medical
rehabilitation. MediClin has approximately 8,200 employees.
End of Corporate News
---------------------------------------------------------------------
11.05.2011 Dissemination of a Corporate News, transmitted by DGAP - a
company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------
Language: English
Company: MediClin AG
Okenstraße 27
77652 Offenburg
Deutschland
Phone: +49 (0)781 488-189
Fax: +49 (0)781 488-184
E-mail: alexandra.muehr(at)mediclin.de
Internet: www.mediclin.de
ISIN: DE0006595101
WKN: 659510
Listed: Regulierter Markt in Frankfurt (Prime Standard);
Freiverkehr in Berlin, Düsseldorf, Hamburg, München,
Stuttgart
End of News DGAP News-Service
---------------------------------------------------------------------
123982 11.05.2011
Datum: 11.05.2011 - 08:54 Uhr
Sprache: Deutsch
News-ID 34029
Anzahl Zeichen: 0
contact information:
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 180 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"DGAP-News: MediClin AG: Sales up by EUR 1.8 mill. in the 1st quarter 2011"
steht unter der journalistisch-redaktionellen Verantwortung von
MediClin AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
